Iron and Clinical Outcomes in Dialysis and Non–Dialysis-Dependent Chronic Kidney Disease Patients

Rouault, 2003, How mammals acquire and distribute iron needed for oxygen-based metabolism, PLoS Biol, 1, e79, 10.1371/journal.pbio.0000079

2006, II. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Adults, Am J Kidney Dis, 47, S16, 10.1053/j.ajkd.2006.03.011

Eschbach, 1999, Iron overload in renal failure patients: Changes since the introduction of erythropoietin therapy, Kidney Int, 55, S35, 10.1046/j.1523-1755.1999.055Suppl.69035.x

Agarwal, 2007, Nonhematological benefits of iron, Am J Nephrol, 27, 565, 10.1159/000107927

Beallo, 1976, Serum ferritin and iron deficiency in patients on chronic hemodialysis, Trans Am Soc Artif Intern Organs, 22, 73

Fernandez-Rodriguez, 1999, Diagnosis of iron deficiency in chronic renal failure, Am J Kidney Dis, 34, 508, 10.1016/S0272-6386(99)70079-X

Kalantar-Zadeh, 1995, Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era, Am J Kidney Dis, 26, 292, 10.1016/0272-6386(95)90649-5

Canavese, 2004, Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients, Kidney Int, 65, 1091, 10.1111/j.1523-1755.2004.00480.x

Fishbane, 2001, A randomized trial of iron deficiency testing strategies in hemodialysis patients, Kidney Int, 60, 2406, 10.1046/j.1523-1755.2001.00077.x

Kaneko, 2003, Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients, Kidney Int, 63, 1086, 10.1046/j.1523-1755.2003.00826.x

Asanuma, 2005, Discrepancy between the percentage of hypochromic erythrocytes and the reticulocyte hemoglobin content in hemodialysis patients with recombinant human erythropoietin therapy, Lab Hematol, 11, 124, 10.1532/LH96.04072

Bovy, 1999, Factors determining the percentage of hypochromic red blood cells in hemodialysis patients, Kidney Int, 56, 1113, 10.1046/j.1523-1755.1999.00627.x

Chiang, 2002, Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients, Clin Nephrol, 58, 363, 10.5414/CNP58363

Canavese, 2000, Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients, Clin Nephrol, 53, 42

Malyszko, 2005, Is hepcidin a link between anemia, inflammation and liver function in hemodialyzed patients?, Am J Nephrol, 25, 586, 10.1159/000089266

Fishbane, 1996, The evaluation of iron status in hemodialysis patients, J Am Soc Nephrol, 7, 2654, 10.1681/ASN.V7122654

Tessitore, 2001, The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin, Nephrol Dial Transplant, 16, 1416, 10.1093/ndt/16.7.1416

Gunnell, 1999, Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients, Am J Kidney Dis, 33, 63, 10.1016/S0272-6386(99)70259-3

Kalantar-Zadeh, 2004, Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients, Nephrol Dial Transplant, 19, 141, 10.1093/ndt/gfg493

Harrison, 1996, The ferritins: Molecular properties, iron storage function and cellular regulation, Biochim Biophys Acta, 1275, 161, 10.1016/0005-2728(96)00022-9

Kwak, 1995, Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha, J Biol Chem, 270, 15285, 10.1074/jbc.270.25.15285

Rogers, 1990, Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1, J Biol Chem, 265, 14572, 10.1016/S0021-9258(18)77341-9

Andrews, 1999, The iron transporter DMT1, Int J Biochem Cell Biol, 31, 991, 10.1016/S1357-2725(99)00065-5

Nemeth, 2004, IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J Clin Invest, 113, 1271, 10.1172/JCI200420945

Ludwiczek, 2003, Cytokine-mediated regulation of iron transport in human monocytic cells, Blood, 101, 4148, 10.1182/blood-2002-08-2459

Kalantar-Zadeh, 2006, The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?, Clin J Am Soc Nephrol, 1, S9, 10.2215/CJN.01390406

Koch, 1976, Occult blood loss and iron balance in chronic renal failure, Proc Eur Dial Transplant Assoc, 12, 362

Lindsay, 1973, The measurement of dialyzer blood loss, Clin Nephrol, 1, 24

Longnecker, 1974, Blood loss during maintenance hemodialysis, Trans Am Soc Artif Intern Organs, 20A, 135

Delano, 1977, Iron absorption in experimental uremia, Nephron, 19, 26, 10.1159/000180862

Goch, 1996, Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test, Nephron, 73, 403, 10.1159/000189100

United States Renal Data System: The USRDS Dialysis Morbidity and Mortality Study (wave 1). 45-67. 1996. U.S. Renal Data System 1996Annual Report 4, Bethesda, MD, National Institute of Health, National Institute of Diabetes, Digestive and Kidney Diseases

Hsu, 2002, Iron status and hemoglobin level in chronic renal insufficiency, J Am Soc Nephrol, 13, 2783, 10.1097/01.ASN.0000034200.82278.DC

Gotloib, 2006, Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron, J Nephrol, 19, 161

Kovesdy, 2009, Association of markers of iron stores with outcomes in patients with non-dialysis dependent CKD, Clin J Am Soc Nephrol, 10.2215/CJN.03980808

Kalantar-Zadeh, 2004, A low serum iron level is a predictor of poor outcome in hemodialysis patients, Am J Kidney Dis, 43, 671, 10.1053/j.ajkd.2003.12.029

Kalantar-Zadeh, 2001, Serum ferritin is a marker of morbidity and mortality in hemodialysis patients, Am J Kidney Dis, 37, 564, 10.1016/S0272-6386(01)80014-7

Kalantar-Zadeh, 2005, Time-dependent associations between iron and mortality in hemodialysis patients, J Am Soc Nephrol, 16, 3070, 10.1681/ASN.2005040423

Ali, 1982, Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy, Lancet, 1, 652, 10.1016/S0140-6736(82)92204-8

Aljama, 1978, Serum ferritin concentration: A reliable guide to iron overload in uremic and hemodialyzed patients, Clin Nephrol, 10, 101

Baker, 1976, Hemosiderosis in a patient on regular hemodialysis: Treatment by desferrioxamine, Clin Nephrol, 6, 326

Gokal, 1979, Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload, Q J Med, 48, 369

Nomura, 1990, Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin, Nephron, 55, 210, 10.1159/000185954

Onoyama, 1990, Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: Confirmation by follow-up liver biopsy, Nephron, 56, 325, 10.1159/000186162

Pitts, 1978, Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients, Nephron, 22, 316, 10.1159/000181469

Stanbaugh, 1984, Dialysis hemosiderosis mimicking non-A, non-B hepatitis, Trans Am Soc Artif Intern Organs, 30, 217

Van de Vyver, 1984, Patterns of iron storage in patients with severe renal failure, Contrib Nephrol, 38, 153, 10.1159/000408081

Gonzalez-Michaca, 2004, Heme: A determinant of life and death in renal tubular epithelial cells, Am J Physiol Renal Physiol, 286, F370, 10.1152/ajprenal.00300.2003

Zhou, 2000, Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis, Lab Invest, 80, 1905, 10.1038/labinvest.3780200

Rao, 2007, Cytokine gene polymorphism and progression of renal and cardiovascular diseases, Kidney Int, 72, 549, 10.1038/sj.ki.5002391

Yilmaz, 2007, Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: Sources and consequences, Clin Nephrol, 68, 1, 10.5414/CNP68001

Aggarwal, 2003, Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin, J Assoc Physicians India, 51, 170

Charytan, 2004, Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products, Nephron Clin Pract, 96, c63, 10.1159/000076401

Charytan, 2005, Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis, Nephron Clin Pract, 100, c55, 10.1159/000085049

Spinowitz, 2008, Ferumoxytol for treating iron deficiency anemia in CKD, J Am Soc Nephrol, 19, 1599, 10.1681/ASN.2007101156

Stoves, 2001, A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin, Nephrol Dial Transplant, 16, 967, 10.1093/ndt/16.5.967

Van Wyck, 2005, A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD, Kidney Int, 68, 2846, 10.1111/j.1523-1755.2005.00758.x

Coyne, 2007, Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: Results of the Dialysis Patients’ Response to IV Iron with Elevated Ferritin (DRIVE) Study, J Am Soc Nephrol, 18, 975, 10.1681/ASN.2006091034

Fudin, 1998, Correction of uremic iron deficiency anemia in hemodialyzed patients: A prospective study, Nephron, 79, 299, 10.1159/000045053

Fishbane, 2003, Safety in iron management, Am J Kidney Dis, 41, 18, 10.1016/S0272-6386(03)00373-1

Zager, 2002, Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury, Am J Kidney Dis, 40, 90, 10.1053/ajkd.2002.33917

Zager, 2004, Parenteral iron therapy exacerbates experimental sepsis, Kidney Int, 65, 2108, 10.1111/j.1523-1755.2004.00742.x

Agarwal, 2004, Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease, Kidney Int, 65, 2279, 10.1111/j.1523-1755.2004.00648.x

Michelis, 2003, Carbonyl stress induced by intravenous iron during haemodialysis, Nephrol Dial Transplant, 18, 924, 10.1093/ndt/gfg031

Agarwal, 2007, Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease, Kidney Int, 72, 638, 10.1038/sj.ki.5002422

Seifert, 1987, von HD, Schaefer K: Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis, Q J Med, 65, 1015

Waterlot, 1985, Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: The critical role of iron overload, Br Med J, 291, 501, 10.1136/bmj.291.6494.501

Feldman, 2002, Iron administration and clinical outcomes in hemodialysis patients, J Am Soc Nephrol, 13, 734, 10.1681/ASN.V133734

Feldman, 2004, Administration of parenteral iron and mortality among hemodialysis patients, J Am Soc Nephrol, 15, 1623, 10.1097/01.ASN.0000128009.69594.BE